ACM
Altium Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,333
| Closed | -$185K | – | 7 |
|
|
2025
Q1 | $185K | Sell |
49,333
-690,667
| -93% | -$2.58M | 0.44% | 18 |
|
|
2024
Q4 | $500K | Hold |
740,000
| – | – | 0.14% | 55 |
|
|
2024
Q3 | $614K | Hold |
740,000
| – | – | 0.18% | 51 |
|
|
2024
Q2 | $642K | Hold |
740,000
| – | – | 0.26% | 35 |
|
|
2024
Q1 | $1.12M | Hold |
740,000
| – | – | 0.44% | 37 |
|
|
2023
Q4 | $640K | Hold |
740,000
| – | – | 0.43% | 32 |
|
|
2023
Q3 | $992K | Hold |
740,000
| – | – | 0.52% | 34 |
|
|
2023
Q2 | $1.32M | Buy |
740,000
+234,219
| +46% | +$419K | 1% | 25 |
|
|
2023
Q1 | $1.97M | Buy |
+505,781
| New | +$1.97M | 1.09% | 33 |
|
|
2022
Q4 | – | Sell |
-750,000
| Closed | -$4.1M | – | 110 |
|
|
2022
Q3 | $4.1M | Buy |
750,000
+50,000
| +7% | +$273K | 1.5% | 19 |
|
|
2022
Q2 | $3.16M | Buy |
700,000
+55,000
| +9% | +$248K | 1.26% | 28 |
|
|
2022
Q1 | $4.75M | Buy |
+645,000
| New | +$4.75M | 1.59% | 21 |
|
|
2021
Q1 | – | Sell |
-133,951
| Closed | -$2.07M | – | 134 |
|
|
2020
Q4 | $2.07M | Buy |
+133,951
| New | +$2.07M | 0.77% | 56 |
|